Global and Europe Oral Proteins and Peptides Market Professional Survey Report 2019

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Global Oral Proteins and Peptides market was valued at XX.0 million US$ in 2018, with the CAGR of 6.0%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Oral Proteins and Peptides market. Describe product range of Oral Proteins and Peptides, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Oral Proteins and Peptides market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Oral Proteins and Peptides market.

     

    By Player

    • Novo Nordisk

    • Tarsa Therapeutics

    • Generex Biotechnology

    • Allergan

    • Hovione

    • AstraZeneca

    • Novartis

    • Sanofi

    • Biocon

    • Hoffmann-La Roche

    • Synthetic Biologics

    • Synergy Pharmaceuticals

    By Type

    • Linaclotide

    • Plecanatide

    • Calcitonin

    • Insulin

    • Octreotide

    By End-User

    • Gastric & Digestive Disorders

    • Bone Diseases

    • Diabetes

    • Hormonal Disorders

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oral Proteins and Peptides Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Oral Proteins and Peptides Market Size and Growth Rate of Linaclotide from 2014 to 2026

      • 1.3.2 Global Oral Proteins and Peptides Market Size and Growth Rate of Plecanatide from 2014 to 2026

      • 1.3.3 Global Oral Proteins and Peptides Market Size and Growth Rate of Calcitonin from 2014 to 2026

      • 1.3.4 Global Oral Proteins and Peptides Market Size and Growth Rate of Insulin from 2014 to 2026

      • 1.3.5 Global Oral Proteins and Peptides Market Size and Growth Rate of Octreotide from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Oral Proteins and Peptides Market Size and Growth Rate of Gastric & Digestive Disorders from 2014 to 2026

      • 1.4.2 Global Oral Proteins and Peptides Market Size and Growth Rate of Bone Diseases from 2014 to 2026

      • 1.4.3 Global Oral Proteins and Peptides Market Size and Growth Rate of Diabetes from 2014 to 2026

      • 1.4.4 Global Oral Proteins and Peptides Market Size and Growth Rate of Hormonal Disorders from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Oral Proteins and Peptides Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Oral Proteins and Peptides Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Oral Proteins and Peptides Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Oral Proteins and Peptides Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Oral Proteins and Peptides Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oral Proteins and Peptides by Major Types

      • 3.4.1 Market Size and Growth Rate of Linaclotide

      • 3.4.2 Market Size and Growth Rate of Plecanatide

      • 3.4.3 Market Size and Growth Rate of Calcitonin

      • 3.4.4 Market Size and Growth Rate of Insulin

      • 3.4.5 Market Size and Growth Rate of Octreotide

    4 Segmentation of Oral Proteins and Peptides Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oral Proteins and Peptides by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oral Proteins and Peptides for Gastric & Digestive Disorders

      • 4.4.2 Market Size and Growth Rate of Oral Proteins and Peptides for Bone Diseases

      • 4.4.3 Market Size and Growth Rate of Oral Proteins and Peptides for Diabetes

      • 4.4.4 Market Size and Growth Rate of Oral Proteins and Peptides for Hormonal Disorders

    5 Market Analysis by Major Regions

    • 5.1 Global Oral Proteins and Peptides Production Analysis by Top Regions

    • 5.2 Global Oral Proteins and Peptides Consumption Analysis by Top Regions

    • 5.3 Global Oral Proteins and Peptides Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Oral Proteins and Peptides Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Oral Proteins and Peptides Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Oral Proteins and Peptides Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Oral Proteins and Peptides Production, Import, Consumption and Export Analysis

    6 Product Circulation of Oral Proteins and Peptides Market among Top Countries

    • 6.1 Top 5 Export Countries in Oral Proteins and Peptides Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Oral Proteins and Peptides Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Oral Proteins and Peptides Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Oral Proteins and Peptides Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Oral Proteins and Peptides Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Oral Proteins and Peptides Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Oral Proteins and Peptides Landscape Analysis

    • 7.1 North America Oral Proteins and Peptides Landscape Analysis by Top Countries

      • 7.1.1 United States Oral Proteins and Peptides Market Volume and Growth Rate

      • 7.1.2 Canada Oral Proteins and Peptides Market Volume and Growth Rate

      • 7.1.3 Mexico Oral Proteins and Peptides Market Volume and Growth Rate

    8. Europe Oral Proteins and Peptides Landscape Analysis

    • 8.1 Europe Oral Proteins and Peptides Landscape Analysis by Major Types

    • 8.2 Europe Oral Proteins and Peptides Landscape Analysis by Major End-Users

    • 8.3 Europe Oral Proteins and Peptides Landscape Analysis by Top Countries

      • 8.3.1 Germany Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.2 UK Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.3 France Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.4 Italy Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.5 Spain Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.6 Belgium Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.7 Poland Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.8 Russia Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.9 Turkey Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.10 Netherlands Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.11 Portugal Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.12 Denmark Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.13 Finland Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.14 Iceland Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.15 Norway Oral Proteins and Peptides Market Volume and Growth Rate

      • 8.3.16 Sweden Oral Proteins and Peptides Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Oral Proteins and Peptides Landscape Analysis

    • 9.1 Asia Pacific Oral Proteins and Peptides Landscape Analysis by Top Countries

      • 9.1.1 China Oral Proteins and Peptides Market Volume and Growth Rate

      • 9.1.2 Japan Oral Proteins and Peptides Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Oral Proteins and Peptides Market Volume and Growth Rate

      • 9.1.4 India Oral Proteins and Peptides Market Volume and Growth Rate

      • 9.1.5 ASEAN Oral Proteins and Peptides Market Volume and Growth Rate

      • 9.1.6 South Korea Oral Proteins and Peptides Market Volume and Growth Rate

    10 LAMEA Oral Proteins and Peptides Landscape Analysis

    • 10.1 LAMEA Oral Proteins and Peptides Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Oral Proteins and Peptides Market Volume and Growth Rate

      • 10.1.2 Brazil Oral Proteins and Peptides Market Volume and Growth Rate

      • 10.1.3 North Africa Oral Proteins and Peptides Market Volume and Growth Rate

      • 10.1.4 South Africa Oral Proteins and Peptides Market Volume and Growth Rate

      • 10.1.5 Argentina Oral Proteins and Peptides Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Novo Nordisk

      • 11.1.1 Novo Nordisk Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Tarsa Therapeutics

      • 11.2.1 Tarsa Therapeutics Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Generex Biotechnology

      • 11.3.1 Generex Biotechnology Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Allergan

      • 11.4.1 Allergan Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Hovione

      • 11.5.1 Hovione Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 AstraZeneca

      • 11.6.1 AstraZeneca Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Novartis

      • 11.7.1 Novartis Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Sanofi

      • 11.8.1 Sanofi Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Biocon

      • 11.9.1 Biocon Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Hoffmann-La Roche

      • 11.10.1 Hoffmann-La Roche Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Synthetic Biologics

      • 11.11.1 Synthetic Biologics Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Synergy Pharmaceuticals

      • 11.12.1 Synergy Pharmaceuticals Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 111 Figures and 139 Tables)

    • Figure Product Picture

    • Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Linaclotide from 2014 to 2026

    • Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Plecanatide from 2014 to 2026

    • Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Calcitonin from 2014 to 2026

    • Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Insulin from 2014 to 2026

    • Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Octreotide from 2014 to 2026

    • Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Gastric & Digestive Disorders from 2014 to 2026

    • Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Bone Diseases from 2014 to 2026

    • Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Diabetes from 2014 to 2026

    • Figure Global Oral Proteins and Peptides Market Size and Growth Rate of Hormonal Disorders from 2014 to 2026

    • Figure North America Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure United States Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure UK Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure France Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure China Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure India Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Oral Proteins and Peptides Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oral Proteins and Peptides Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oral Proteins and Peptides

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oral Proteins and Peptides by Different Types from 2014 to 2026

    • Table Consumption Share of Oral Proteins and Peptides by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Linaclotide

    • Figure Market Size and Growth Rate of Plecanatide

    • Figure Market Size and Growth Rate of Calcitonin

    • Figure Market Size and Growth Rate of Insulin

    • Figure Market Size and Growth Rate of Octreotide

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oral Proteins and Peptides by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oral Proteins and Peptides by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Gastric & Digestive Disorders

    • Figure Market Size and Growth Rate of Bone Diseases

    • Figure Market Size and Growth Rate of Diabetes

    • Figure Market Size and Growth Rate of Hormonal Disorders

    • Table Global Oral Proteins and Peptides Production by Major Regions

    • Table Global Oral Proteins and Peptides Production Share by Major Regions

    • Table Global Oral Proteins and Peptides Consumption by Major Regions

    • Table Global Oral Proteins and Peptides Consumption Share by Major Regions

    • Table North America Oral Proteins and Peptides Production, Import, Consumption and Export Analysis

    • Table Europe Oral Proteins and Peptides Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Oral Proteins and Peptides Production, Import, Consumption and Export Analysis

    • Table LAMEA Oral Proteins and Peptides Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Oral Proteins and Peptides Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Oral Proteins and Peptides Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Oral Proteins and Peptides Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Oral Proteins and Peptides Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Oral Proteins and Peptides Consumption by Major Countries from 2014 to 2026

    • Table North America Oral Proteins and Peptides Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Oral Proteins and Peptides Consumption Share by Major Countries in 2014

    • Figure North America Oral Proteins and Peptides Consumption Share by Major Countries in 2018

    • Figure North America Oral Proteins and Peptides Consumption Share by Major Countries in 2026

    • Figure United States Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Oral Proteins and Peptides Consumption by Types from 2014 to 2026

    • Table Europe Oral Proteins and Peptides Consumption Share by Types from 2014 to 2026

    • Table Europe Oral Proteins and Peptides Consumption by End-Users from 2014 to 2026

    • Table Europe Oral Proteins and Peptides Consumption Share by End-Users from 2014 to 2026

    • Table Europe Oral Proteins and Peptides Consumption by Major Countries from 2014 to 2026

    • Table Europe Oral Proteins and Peptides Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure France Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Oral Proteins and Peptides Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Oral Proteins and Peptides Consumption Share by Major Countries from 2014 to 2026

    • Figure China Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure India Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Oral Proteins and Peptides Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Oral Proteins and Peptides Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Oral Proteins and Peptides Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Tarsa Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tarsa Therapeutics

    • Figure Sales and Growth Rate Analysis of Tarsa Therapeutics

    • Figure Revenue and Market Share Analysis of Tarsa Therapeutics

    • Table Product and Service Introduction of Tarsa Therapeutics

    • Table Company Profile and Development Status of Generex Biotechnology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Generex Biotechnology

    • Figure Sales and Growth Rate Analysis of Generex Biotechnology

    • Figure Revenue and Market Share Analysis of Generex Biotechnology

    • Table Product and Service Introduction of Generex Biotechnology

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Hovione

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hovione

    • Figure Sales and Growth Rate Analysis of Hovione

    • Figure Revenue and Market Share Analysis of Hovione

    • Table Product and Service Introduction of Hovione

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Company Profile and Development Status of Hoffmann-La Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hoffmann-La Roche

    • Figure Sales and Growth Rate Analysis of Hoffmann-La Roche

    • Figure Revenue and Market Share Analysis of Hoffmann-La Roche

    • Table Product and Service Introduction of Hoffmann-La Roche

    • Table Company Profile and Development Status of Synthetic Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthetic Biologics

    • Figure Sales and Growth Rate Analysis of Synthetic Biologics

    • Figure Revenue and Market Share Analysis of Synthetic Biologics

    • Table Product and Service Introduction of Synthetic Biologics

    • Table Company Profile and Development Status of Synergy Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synergy Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Synergy Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Synergy Pharmaceuticals

    • Table Product and Service Introduction of Synergy Pharmaceuticals

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.